WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000058339) 50 HUMAN SECRETED PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/058339    International Application No.:    PCT/US2000/007440
Publication Date: 05.10.2000 International Filing Date: 22.03.2000
Chapter 2 Demand Filed:    25.10.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: HUMAN GENOME SCIENCES, INC. [US/US]; 9410 Key West Avenue, Rockville, MD 20850 (US) (For All Designated States Except US).
ROSEN, Craig, A. [US/US]; (US) (For US Only).
RUBEN, Steven, M. [US/US]; (US) (For US Only).
KOMATSOULIS, George [US/US]; (US) (For US Only)
Inventors: ROSEN, Craig, A.; (US).
RUBEN, Steven, M.; (US).
KOMATSOULIS, George; (US)
Agent: HOOVER, Kenley, K.; Human Genome Sciences, Inc., 9410 Key West Avenue, Rockville, MD 20850 (US)
Priority Data:
60/126,503 26.03.1999 US
60/172,409 17.12.1999 US
Title (EN) 50 HUMAN SECRETED PROTEINS
(FR) 50 PROTEINES HUMAINES SECRETEES
Abstract: front page image
(EN)The present invention relates to 50 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
(FR)L'invention concerne 50 nouvelles protéines humaines sécrétées et des acides nucléiques isolés contenant les zones de codage des gènes codant ces protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des méthodes de recombinaison permettant de produire des protéines humaines sécrétées. L'invention se rapporte en outre à des méthodes diagnostiques et thérapeutiques utiles dans le diagnostic et le traitement de maladies, de troubles, et/ou d'états pathologiques liés à ces nouvelles protéines humaines sécrétées.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)